Marker Therapeutics Inc (MRKR)

[BluMarlin1960]

Not coaching just common sense, as to what gets us to $30, Glynn made a prediction Nov 18/2014 in a public interview [unprecedented] that TPIV would be worth "1billion" within 5 years. Look it up.

But I am simply doing the math "realistically", within the past 2 years a number of companies have been bought out for in excess of 1 billion dollars. With technology not as compelling as ours, and not nearly as well structured or having our pipeline.

A buyout/merger if the science pans out in early Phase 11, is in no way out of the question, and as per Glynn's comments, a buyout will not be entertained under a billion.

So do the math on OS, existing warrants, then do the math as to what gets us minimally to 1 billion, once again Herceptin 6.7 Billion annually, and only treats 15% of population, opposed to TPIV 84% broad based coverage.

And to my understanding Herceptin may only be administered for 1 year at a time, combined with negative side effects.

TPIV needs these initial Phase 11's to validate that price tag, once again we are in a state of flux here, everything hinges on the initial Phase 11 data.

I have looked at every possible negative scenario, fundamentals look very strong here, data will confirm or decimate this ticker.

Once again if we have the goods, many will try to undermine to get their hands on technology before this ends.

BLU